References
- 1. Turcotte RE. Giant cell tumor of bone. Orthop Clin North Am. 2006; 37(1):35–51.
- 2. Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH. Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res. 2011; 469(2):591–9.
- 3. McGrath PJ. Giant-cell tumour of bone: an analysis of fifty-two cases. J Bone Joint Surg Br. 1972; 54(2):216–29.10.1302/0301-620X.54B2.216
- 4. Bertoni F, Present D, Sudanese A, Baldini N, Bacchini P, Campanacci M. Giant-cell tumor of bone with pulmonary metastases. Six case reports and a review of the literature. Clin Orthop Relat Res. 1988; 237(2):275–85.
- 5. Jaffe HL, Portis RB. Giant Cell Tumor of Bone. Its Pathologic Appearance, Grading, Supposed Variants, and Treatment. Arch Pathology. 1940; 30:993.
- 6. Donthineni R, Boriani L, Ofluoglu O, Bandiera S. Metastatic behaviour of giant cell tumour of the spine. Int Orthop. 2009; 33:497.10.1007/s00264-008-0560-9
- 7. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 2003; 415:4–18.
- 8. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. 4th edition., 2013, International Agency for Research on Cancer, Lyon.
- 9. Dahlin DC, Cupps RE, Johnson EW Jr. Giant-cell tumor: a study of 195 cases. Cancer. 1970; 25(5):1061–70.
- 10. Camargo OPO. Estado da arte no diagnóstico e tratamento do tumor de células gigantes. Rev Bras Ortop. 2002; 37(10):424–9.
- 11. Kivioja AH, Blomqvist C, Hietaniemi K, Trovik C, Walloe A, Bauer HC, Jorgensen PH, Bergh P, Follerås G. Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop. 2008; 79(1):86–93. doi: 10.1080/17453670710014815.10.1080/17453670710014815
- 12. Lewis VO, Wei A, Mendoza T, Primus F, Peabody T, Simon MA. Argon beam coagulation as an adjuvant for local control of giant cell tumor. Clin Orthop Relat Res. 2007; 454:192–197. doi: 10.1097/01.blo.0000238784.98606. d4.10.1097/01.blo.0000238784.98606.d4
- 13. Chen TH, Su YP, Chen WM. Giant cell tumors of the knee: subchondral bone integrity affects the outcome. Int Orthop. 2005; 29(1):30–34. doi: 10.1007/s00264-004-0613-7.10.1007/s00264-004-0613-7
- 14. Ward WG, Sr, Gird L. Customized treatment algorithm for giant cell tumor of bone: report of a series. Clin Orthop Relat Res. 2002; 397:259–270. doi: 10.1097/00003086-200204000-00030.10.1097/00003086-200204000-00030
- 15. W. Guo, T. Ji, R. Yang, X. Tang, Y. Yang. Endoprosthetic replacement for primary tumours around the knee: experience from Peking University. J Bone Jt Surg Br. 2008; 90:1084-1089. https://doi.org/10.1302/0301-620X.90B8.2024010.1302/0301-620X.90B8.20240
- 16. Pala EMA, Mavrogenis AF, Angelini A, Henderson ER, Douglas Letson G, Ruggieri P. Cemented versus cementless endoprostheses for lower limb salvage surgery. J Buon. 2013; 18(2):496-503.
- 17. Willert HG, Semlitsch M. Reactions of the articular capsule to wear products of artificial joint prostheses. J. Biomed. Mater. Res. 1977; 11:157-164, 10.1002/ jbm.820110202.
- 18. La Verde L, Fenga D, Spinelli MS, Rosario Campo F, Florio M, Attilio Rosa M. Catastrophic metallosis after tumoral knee prosthesis failure: A case report. International Journal of Surgery Case Reports. 2017;30:9-12. https://doi.org/10.1016/j.ijscr.2016.11.023.10.1016/j.ijscr.2016.11.023